Evidence map›Paper›PMID 31572525›Full record

ArticleExperimental and therapeutic medicine2019

Investigation of leukocyte

Irfan V Düzen, Fethi Yavuz, Ertan Vuruskan, Erhan Saracoglu, Fatih Poyraz, Yusuf Cekici, Hayri Alıcı, Hüseyin Göksülük, Basar Candemir, Murat Sucu and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Irfan V DüzenDepartment of Cardiology, Faculty of Medicine, University of Gaziantep, Gaziantep 27310, Turkey.
Fethi YavuzDepartment of Cardiology, Adana City Hospital, Adana 01060, Turkey.
Ertan VuruskanDepartment of Cardiology, Faculty of Medicine, University of Gaziantep, Gaziantep 27310, Turkey.
Erhan SaracogluDepartment of Cardiology, Dr Ersin Arslan Education and Research Hospital, Gaziantep 27310, Turkey.
Fatih PoyrazDepartment of Cardiology, Defa Life Hospital, Gaziantep 27310, Turkey.
Yusuf CekiciDepartment of Cardiology, Dr Ersin Arslan Education and Research Hospital, Gaziantep 27310, Turkey.
Hayri AlıcıDepartment of Cardiology, Hatem Hospital, Gaziantep 27310, Turkey.
Hüseyin GöksülükDepartment of Cardiology, Faculty of Medicine, Ankara University, Ankara 06340, Turkey.
Basar CandemirDepartment of Cardiology, Faculty of Medicine, Ankara University, Ankara 06340, Turkey.
Murat SucuDepartment of Cardiology, Faculty of Medicine, University of Gaziantep, Gaziantep 27310, Turkey.
Abdullah T DemiryürekDepartment of Medical Pharmacology, Faculty of Medicine, University of Gaziantep, Gaziantep 27310, Turkey.
Gaziantep University · TRAnkara University · TRGaziantep Children's Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) is an arrhythmia caused by disorganized electrical activity in the atria, and it is an important cause of mortality and morbidity. There is a limited data about Rho/Rho-kinase (ROCK) pathway contribute to AF development. The aim of the present study was to elucidate leukocyte

Indexed as

atrial fibrillationgene expressionpolymerase chain reactionRho-kinaseRho proteins

Identifiers

PMID31572525
PMCPMC6755446
OpenAlexW2969879683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.